Breast Carcinoma — Trials

Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,394 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 873
Recruiting: 478
Ph III recruiting: 55
Growth YoY: −2.3%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 40.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (365)

clinicaltrialsPublishedShowing 251–300 of 427 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03384914	Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer	active not recruiting	Phase 2	119	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Mar 6, 2026	clinicaltrials
NCT06268665	Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy	recruiting	Phase 2	86	University of California, DavisOTHER	1	Mar 4, 2026	clinicaltrials